相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function
Chunzhang Yang et al.
FASEB JOURNAL (2012)
Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant
Inna Bendikov-Bar et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Histone Deacetylase Cytoplasmic Trapping by a Novel Fluorescent HDAC Inhibitor
Yali Kong et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function
Chunzhang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease
Jie Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts
Nina H. Pipalia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD
Emilie Tresse et al.
AUTOPHAGY (2010)
Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease
Idit Ron et al.
HUMAN MOLECULAR GENETICS (2010)
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Darren M. Hutt et al.
NATURE CHEMICAL BIOLOGY (2010)
Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl
Jie Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
被撤回的出版物: HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling (Retracted article. See vol. 295, pg. 297, 2020)
Vikram D. Kekatpure et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Focal Nature of Neurological Disorders Necessitates Isotype-Selective Histone Deacetylase (HDAC) Inhibitors
Elizabeth A. Thomas
MOLECULAR NEUROBIOLOGY (2009)
Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo
Giuseppe Faraco et al.
NEUROBIOLOGY OF DISEASE (2009)
Dominant-negative Hsp90 reduces VEGF-stimulated nitric oxide release and migration in endothelial cells
Robert Q. Miao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Gaucher disease:: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Kathleen S. Hruska et al.
HUMAN MUTATION (2008)
Inhibition of p97-dependent protein degradation by Eeyarestatin I
Qiuyan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Intracellular cholesterol modifies the ERAD of glucocerebrosidase in Gaucher disease patients
Idit Ron et al.
MOLECULAR GENETICS AND METABOLISM (2008)
FK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70
Ying Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions
Andy Dong-Anh Tran et al.
JOURNAL OF CELL SCIENCE (2007)
An acetylation site in the middle domain of Hsp90 regulates chaperone function
Bradley T. Scroggins et al.
MOLECULAR CELL (2007)
Improved intracellular delivery of glucocerebrosidase mediated by the HIV-1 TAT protein transduction domain
KO Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Modulating molecular chaperone Hsp90 functions through reversible acetylation
S Aoyagi et al.
TRENDS IN CELL BIOLOGY (2005)
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity
I Ron et al.
HUMAN MOLECULAR GENETICS (2005)
Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
P Bali et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An expression screen reveals modulators of class II histone deacetylase phosphorylation
SR Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation
XY Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
E Hockly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70
CA Johnson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Valosin-containing protein is a multiubiquitin chain targeting factor required in ubiquitin-proteasome degradation
RM Dai et al.
NATURE CELL BIOLOGY (2001)
The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins
P Connell et al.
NATURE CELL BIOLOGY (2001)
分享论文
